최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
DataON 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Edison 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Kafe 바로가기주관연구기관 | 서울대학교 Seoul National University |
---|---|
연구책임자 | 장판식 |
참여연구자 | 백현동 , 최승준 |
보고서유형 | 최종보고서 |
발행국가 | 대한민국 |
언어 | 한국어 |
발행년월 | 2017-04 |
주관부처 | 농림축산식품부 Ministry of Agriculture, Food and Rural Affairs(MAFRA) |
등록번호 | TRKO201800009769 |
DB 구축일자 | 2018-05-26 |
키워드 | 난용성 생리활성 소재.분지아미노산.리포좀-탑재 미세캡슐.나노-마이크로 에멀젼.생체이용률.Non soluble bioactive compound.Brached chain amino acid.Liposome encapsulation.Nano/microemulsion.Bioavailability. |
DOI | https://doi.org/10.23000/TRKO201800009769 |
● 분지아미노산의 생체이용률 개선방법으로서 나노/마이크로에멀젼 제조 및 리포좀-탑재 미세캡슐화 기술을 개발함(SCI급 논문: 14편 게재, 국내특허출원: 3건, PCT출원: 1건, 국내특허등록: 1건, 기술이전: 1건)
● 분지아미노산 생체이용률 개선 기술을 적용한 소재를 in vitro, ex vivo 및 in vivo 모델에서 생체이용률/생리활성을 종합적으로 평가함
(SCI급 논문: 1편 게재, 국내특허출원: 3건)
● 생체이용률이 개선된 분지아미노산 소재의 제품규격기준 설정, 대량생산 체제 구축
● 분지아미노산의 생체이용률 개선방법으로서 나노/마이크로에멀젼 제조 및 리포좀-탑재 미세캡슐화 기술을 개발함(SCI급 논문: 14편 게재, 국내특허출원: 3건, PCT출원: 1건, 국내특허등록: 1건, 기술이전: 1건)
● 분지아미노산 생체이용률 개선 기술을 적용한 소재를 in vitro, ex vivo 및 in vivo 모델에서 생체이용률/생리활성을 종합적으로 평가함
(SCI급 논문: 1편 게재, 국내특허출원: 3건)
● 생체이용률이 개선된 분지아미노산 소재의 제품규격기준 설정, 대량생산 체제 구축 및 공정 표준화를 통해 산업화 함(제품화: 4종)
(출처 : 요약서 3p)
Purpose&Contents
▣[Comprehensive research goals]
In this research, we tried to develop nano/microemulsion and nano-sized liposome-loaded microencapsulation technology and evaluate bioavailability and biological activity for improving bioavailability of insoluble branched chain amino acids(BCAA
Purpose&Contents
▣[Comprehensive research goals]
In this research, we tried to develop nano/microemulsion and nano-sized liposome-loaded microencapsulation technology and evaluate bioavailability and biological activity for improving bioavailability of insoluble branched chain amino acids(BCAAs). Moreover, we tried to achieve practical application by the technology and commercialization of insoluble bioactive compounds(BCAAs) by standardizing the mass production system.
▣[Specific research goals]
● We developed nano/microemulsion and liposome-loaded microencapsulation technology for method to improve the bioavailability of BCAAs.
● We comprehensively evaluated bioavailability and biological activity by using in vitro, ex vivo, and in vivo models for confirmation of insoluble BCAAs which are applied to bioavailability improvement technique.
● We established product standards for BCAAs with improved bioavailability, industrialized through mass production system and process standardization.
▣ [Research contents]
○ Manufacture of BCAAs encapsulated in liposomes and development of controlled release micro-encapsulation technology
● Development of liposome and evaluation of physicochemical properties
● Development of controlled release micro-encapsulation technology and evaluation of physicochemical properties
● Evaluation of liposome nad microcapsule’s stability and in bioavailability in simulated digestion models
○ Development of improved bioavailability of branched amino acid from customized materials and food
● Development of high-stability emulsification technology for food materials of physiologically non-soluble bio-active compound
● Application of nano/microemulsion technology for solubilization of BCAAs
● Evaluation of storage stability and release mechanism of solubilized BCAAs through nano/microemulsion manufacturing technology
○ Evaluation of bioavailability and physiological activity of BCAAs prepared by liposome-loaded microcapsules and nano / microemulsion technology
● Establishment of analytical method for functionality of BCAAs and validation of bioactivity in vitro and ex vivo
● Evaluation of bioavailability and bioactivity of BCAAs in food and in vitro and ex vivo
● Evaluation of in vivo for bioavailability and bioactivity of produced prototype
○ Commercialization of branched amino acid with improved bioavailability through development of solubilization technology
● Development of solubilization technology for non-soluble materials and selection of composition rate
● Analysis of preference special group, development of amino acid product and sensory evaluation
● Production of BCAAs and evaluation of using functional materials
Results
Expected Contribution
● We established on theoretical bases for application of non-solubility bioactive compound and suggest an basic research background. In addtion, as a research from the stage of technological development such as verification, production of actually application goods, we can anticipate the superiority of technology in international competitive and expect a leading group in related research fields.
● Quantitative performance goals: 14 SCI-grade papers, 7 patents, and 4 products.
(출처 : SUMMARY 6p)
과제명(ProjectTitle) : | - |
---|---|
연구책임자(Manager) : | - |
과제기간(DetailSeriesProject) : | - |
총연구비 (DetailSeriesProject) : | - |
키워드(keyword) : | - |
과제수행기간(LeadAgency) : | - |
연구목표(Goal) : | - |
연구내용(Abstract) : | - |
기대효과(Effect) : | - |
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.